Close
Get  Appointment!
Get  Appointment!
Facebook
Twitter
Dribbble
Behance
Home
About
Services
Contact
Get in touch
Info@example.com
Privacy Policy
© 2024 Ovicare
hero image

The health 45 Investment Opportunity

single image 1
icon 2
Health 45 is an innovative investment opportunity at the crossroads of healthcare, wellness, and a growing demand for effective weight-loss solutions.

By focusing on two dynamic ventures—Envigore and Reakiro—Health 45 brings a holistic approach to tackling one of the world’s most pressing health issues: obesity and the chronic conditions it triggers.
‍

Why Invest in Health 45?

Untapped Market Potential

Obesity affects 63% of UK adults, with public healthcare systems reaching only a fraction of those seeking treatment. Demand for clinically approved weight-loss treatments far outstrips supply. Health 45 addresses this massive underserved segment.

Holistic Wellness Approach

Beyond weight loss, Health 45 embraces a lifetime of health maintenance. Our synergy of Envigore’s weight-loss solutions and Reakiro’s wellness portfolio creates a continuous pathway from initial treatment to long-term wellbeing.

High-Growth Health Sector

The global shift toward preventative healthcare, telemedicine, and holistic wellness underpins a rapidly expanding sector. As more individuals prioritise weight management and overall health, Health 45 is poised to meet that demand with robust, patient-focused brands.

Diverse Investment Structures

Secured Loan Note (SLN) – A structured debt instrument.
‍Limited Partnership (LP) – A partnership model offering direct exposure to the underlying health ventures.
‍Investment Bond – Another route that aligns with specific portfolio strategies and investor preferences.

process image
icon 2

Key Highlights

randoms

Strategic Integration

Health45 invests in forward-thinking healthcare companies tackling obesity and chronic wellness gaps. We target ventures with proven efficacy, regulatory compliance, and scalable models.

randoms

Regulatory Edge

Envigore partners with established pharmacy networks to ensure compliance and streamline telemedicine, while Reakiro adheres to strict quality standards in nutraceuticals.

randoms

High Retention & Upsell

Ongoing wellness offerings keep customers engaged beyond an initial weight-loss prescription, creating a longer customer lifecycle.

randoms

Versatile Investment Routes

Choose from our Secured Loan Note, Limited Partnership, or Investment Bond, each structured to accommodate HNW and Sophisticated Investors’ diverse objectives.

How it works

story image
icon 2

Identification & Acquisition

Health 45 invests in forward-thinking healthcare companies tackling obesity and chronic wellness gaps. We target ventures with proven efficacy, regulatory compliance, and scalable models.

Strategic Integration

Our portfolio companies—Envigore and Reakiro—offer complementary services. Together, they deliver end-to-end wellness pathways, positioning Health 45 as a robust ecosystem.

Steady Growth

By meeting the urgent need for weight-loss treatments and supplementing with long-term wellness products, Health45 opens doors to multiple revenue streams and sustained brand loyalty.

Request

icon 1

More Information

We believe in transparent disclosure of all investment details and risks.

To proceed, you must confirm that you are a Sophisticated Investor, a High Net Worth Individual, or a regulated financial professional.  Click below to request our brochure and term sheets. If you do not meet one of these criteria, please do not continue.

Contact us
icon 6
“At Health45, we believe better health shouldn’t be out of reach—our investments aim to make life-changing solutions accessible to millions.”
Risk Warning:
“Investing involves risks, including potential loss of capital. This promotion is directed at eligible investors under the Financial Promotion Order-others should not rely on it. Past performance is not indicative of future results.”
No Advice Statement:
“This content is for informational purposes only and does not constitute investment, tax, or legal advice. Prospective investors should consult independent advisors.”
‍Regulatory Status:
“Health 45 is not authorised by the FCA. Information is provided under exemptions for high-net-worth, sophisticated, and professional investors, as defined in the UK Financial Services and Markets Act (Financial Promotion) Order.”